Labshake search
Citations for R&D Systems :
151 - 200 of 3503 citations for 7 Butyl 8 mercapto 1 3 dimethyl 3 7 dihydro purine 2 6 dione since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2022Quote: ... or 1:1000 anti-Human/Mouse/Rat PRL-3 Antibody (R&D Systems, MAB3219, Lot. WXH0419091). Following three washes with 0.1% TBST ...
-
bioRxiv - Immunology 2020Quote: ... mouse or human T-cells were cultured with mouse or human IL-7 (10 ng/mL) (R&D Systems) or tacrolimus (Sigma-Aldrich) ...
-
bioRxiv - Developmental Biology 2022Quote: ... Explants were either treated with recombinant BMP2/7 heterodimers (32 nM, R&D Systems, Cat No. 3229-BM-010) or Noggin (300 ng/μl ...
-
bioRxiv - Microbiology 2021Quote: ... and IGFBP-3 DuoSet ELISA kit (R&D Systems), respectively ...
-
bioRxiv - Developmental Biology 2020Quote: ... Rabbit α-Active Caspase-3 (R&D Systems, #AF835), Mouse α-PAX7 (DSHB) ...
-
bioRxiv - Developmental Biology 2020Quote: ... supplemented with BMP4 (3 ng/ml, R&D Systems) and Thiazovivin (2 μM ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Immunology 2020Quote: ... LAG-3 (Polyclonal, R&D Systems, Minneapolis, MN, USA), CD123 (clone 7G3) ...
-
bioRxiv - Bioengineering 2021Quote: ... 20ng/mL IL-3 (R&D Systems 203-IL), 20 ng/mL G-CSF (R&D Systems 214-CS) ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.01µg/mL IL-3 (R&D Systems, 203-IL) and 0.005µg/mL TNFα (R&D Systems ...
-
bioRxiv - Cell Biology 2021Quote: ... with 20 ng/ml rmIL-3 (R&D Systems), 50 ng/ml Flt3-Ligand (R&D Systems ...
-
bioRxiv - Genetics 2019Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-cleaved caspase 3 were from R&D Systems.
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... 3 ng/ml rhBMP4 (R&D Systems, #314-BP), and 3 ng/ml rmWNT3a (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... and 25 ng/ml rhIL-3 (R&D Systems). Macrophage precursor cells could be routinely harvested from dishes containing EBs every 6/7 days for up to 3/4 months ...
-
bioRxiv - Immunology 2024Quote: ... anti-LAG-3 (polyclonal goat IgG, R&D Systems), anti-PD-1 (cloneEH12.1 ...
-
bioRxiv - Cell Biology 2022Quote: ... CXCL1 levels were measured after 3 h and 6 h using the Human CXCL1/GROα DuoSet® ELISA kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.1 million cells (in 100 µL of 1:1 mix of PBS and Cultrex Basement Membrane Extract (Type 3, R&D systems)) were injected into the 4th mammary fat pad of 7-8 weeks old female BALB/c mice ...
-
bioRxiv - Developmental Biology 2020Quote: ... and the combination treatment of Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3). At Day2 ...
-
bioRxiv - Microbiology 2021Quote: ... DY210) were quantified in the supernatants from uninfected and SARS-CoV-2-infected Calu-3 cells by ELISA (R&D Systems), following manufacturer’s instructions ...
-
bioRxiv - Immunology 2020Quote: IL-6 and IL-8 was measured using duo set ELISAs from R&D Systems according to manufactures instructions.
-
bioRxiv - Developmental Biology 2022Quote: Primary antibodies used were rabbit anti-Human Phospho-Smad2/3 (R&D Systems MAB8935, 1:500 dilution), goat anti-histone (Abcam ab12079 ...
-
bioRxiv - Cancer Biology 2023Quote: ... The following primary antibodies were used: rabbit anti active caspase 3 (1:200; R&D Systems AF835), and rabbit anti-Ki67 (1:5000 ...
-
bioRxiv - Cell Biology 2023Quote: Immunohistochemistry was performed with the following antibodies: Cleaved Caspase 3 (rabbit, R&D Systems, MAB835, 1:100), Hopx (mouse ...
-
bioRxiv - Biophysics 2021Quote: ... was accessed by testing the hydrolysis of 2.5 µM Substrate V (7-methoxycoumarin-4-yl-acetyl-RPPGFSAFK-2,4-dinitrophenyl, R&D Systems), a previously known fluorogenic substrate of IDE ...
-
bioRxiv - Immunology 2022Quote: ... plated at 1-2×104 cells/well in 96 U-bottom plate and cultured for 3 – 6 days in cRPMI medium in the presence of IL-33 (R&D Systems, #3626, 50 ng/ml) or TSLP (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 3 nM Shh (1845-SH; R&D Systems), as used in Ohyama et al (2005 ...
-
bioRxiv - Microbiology 2020Quote: ... GM-CSF and IL-3 [all from R&D Systems]) ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/mL recombinant murine IL-3 (R&D Systems, and 5% stem cell factor-containing supernatant from CHO-KL cells for 4-6 weeks until maturation ...
-
bioRxiv - Bioengineering 2021Quote: ... and 3 U/mL EPO (R&D Systems 287-TC). Cells were cultured for 7 days followed EHT and assessed using by flow cytometry.
-
bioRxiv - Developmental Biology 2022Quote: ... we used a SMAD2/3 antibody (R&D systems, AF3797) in 2X10^6 hESCs that were treated with Activin for 2 h or 24 h with or without Wnt priming ...
-
bioRxiv - Molecular Biology 2019Quote: ... followed by treatment with 3 nM BMP4(R&D Systems), 50 pg/ml TGF-β1 (R&D Biosystems) ...
-
bioRxiv - Immunology 2019Quote: ... IFNα (3×104 units/ml, R&D Systems, Minneapolis, MN), (3 ...
-
bioRxiv - Physiology 2021Quote: ... phrixotoxin-3 (PTx3) (R&D Systems, Cat # 4914. 15 μM); phenytoin (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2021Quote: ... goat polyclonal anti-mouse VEGFR-3 (R&D Systems, AF743) and rabbit polyclonal anti-RFP (Rockland ...
-
bioRxiv - Cell Biology 2022Quote: ... Mouse Galectin-3 DuoSet (all from R&D Systems,UK).
-
bioRxiv - Immunology 2023Quote: ... 30 ng/ml IL-3 (R&D Systems, 203-IL), 30 ng/ml TPO (PeproTech ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 days with 200 ng/mL FGF9 (R&D Systems), 1 μg/mL heparin (Sigma-Aldrich) ...
-
bioRxiv - Bioengineering 2023Quote: ... and 3 µM CHIR99021 (C) (R&D Systems, 4423/50).
-
bioRxiv - Cancer Biology 2023Quote: ... 10 ng/ml rhIL-3 (#203-IL, R&D Systems) and 10 ng/ml rhIL-6 (#206-IL ...
-
bioRxiv - Immunology 2023Quote: ... IL-3 (5.3 ng/ml; R&D Systems, 203-IL), CXCL12 (9.7 ng/ml ...
-
bioRxiv - Immunology 2023Quote: ... IL-3 (0.97 ng/ml; R&D Systems, 203-IL), CXCL12 (97.39 ng/ml) ...
-
bioRxiv - Cell Biology 2023Quote: ... and human total MMP-3 (R&D Systems, cat.# DY513) according to manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2024Quote: ... Neurotrophin-3 (1ug/ml, 267-N3-025, R&D Systems), and Doxycycline Hydrochloride (1ug/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... Neurotrophin-3 (1ug/ml, 267-N3-025, R&D Systems), EdU (5-ethynyl-2’-deoxyuridine ...
-
bioRxiv - Microbiology 2024Quote: Recombinant Gal-3 (R&D Systems, Cat# 1197-GA-050) was pre-diluted in phosphate-buffered saline (PBS ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng/mL NT-3 (R&D Systems, 267-N3), 10 ng/mL EGF ...